Search research articles
Contact Us
Filters
Showing results (291-300 of 343) with videos related to
Page
of 35
Sort By:
Blood
|
June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance
Guang Yang, Jinhua Wang, Li Tan, et al.
Blood Cancer Journal
|
July 8, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia
Maria Luisa Guerrera, Xia Liu, Nickolas Tsakmaklis, et al.
British Journal of Haematology
|
April 20, 2025
Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia
Shirong Liu, Xia Liu, Choudhury Fabliha Binte Yusuf, et al.
Blood
|
February 24, 2016
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia
Aldo M Roccaro, Antonio Sacco, Jiantao Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2020
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Steven P Treon, Lian Xu, Maria Luisa Guerrera, et al.
Blood
|
July 21, 2021
Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia
Steven P Treon, Kirsten Meid, Zachary R Hunter, et al.
Leukemia & Lymphoma
|
July 7, 2020
Primary refractory multiple myeloma: a real-world experience with 85 cases
Artur Jurczyszyn, Anna Waszczuk-Gajda, Jorge J Castillo, et al.
Leukemia & Lymphoma
|
January 5, 2016
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients
Artur Jurczyszyn, Magdalena Olszewska-Szopa, Vania Hungria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2021
Venetoclax in Previously Treated Waldenström Macroglobulinemia
Jorge J Castillo, John N Allan, Tanya Siddiqi, et al.
Seminars in Hematology
|
April 26, 2023
Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia
Ramón Garcia-Sanz, Marzia Varettoni, Cristina Jiménez, et al.
Page
of 35
Search research articles
Search
Showing results (291-300 of 343) with videos related to
Sort By:
Page
of 35
Blood
|
June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance
Guang Yang, Jinhua Wang, Li Tan, et al.
Blood Cancer Journal
|
July 8, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia
Maria Luisa Guerrera, Xia Liu, Nickolas Tsakmaklis, et al.
British Journal of Haematology
|
April 20, 2025
Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia
Shirong Liu, Xia Liu, Choudhury Fabliha Binte Yusuf, et al.
Blood
|
February 24, 2016
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia
Aldo M Roccaro, Antonio Sacco, Jiantao Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2020
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Steven P Treon, Lian Xu, Maria Luisa Guerrera, et al.
Blood
|
July 21, 2021
Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia
Steven P Treon, Kirsten Meid, Zachary R Hunter, et al.
Leukemia & Lymphoma
|
July 7, 2020
Primary refractory multiple myeloma: a real-world experience with 85 cases
Artur Jurczyszyn, Anna Waszczuk-Gajda, Jorge J Castillo, et al.
Leukemia & Lymphoma
|
January 5, 2016
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients
Artur Jurczyszyn, Magdalena Olszewska-Szopa, Vania Hungria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2021
Venetoclax in Previously Treated Waldenström Macroglobulinemia
Jorge J Castillo, John N Allan, Tanya Siddiqi, et al.
Seminars in Hematology
|
April 26, 2023
Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia
Ramón Garcia-Sanz, Marzia Varettoni, Cristina Jiménez, et al.
Page
of 35